welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
completed
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
study id #: NCT01380964
condition: Duchenne Muscular Dystrophy (DMD)
status: completed
purpose:The purpose of this study is to identify potential biomarkers for the diagnosis, disease progression assessment and response to treatment in patients with Duchenne Muscular Dystrophy.
mechanism of action: No pharmaceutical intervention
results: https://clinicaltrials.gov/ct2/show/results/NCT01380964
last updated: November 21, 2018
study details
study contacts
rareRelated
-
Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD)The primary objective of this Expanded A...
-
2D Strain Evaluation: Children With Duchenne Muscular Dystrophy Versus Healthy ChildrenCompare systolic function of left ventri...
-
Antisense Therapeutics to commence muscular dystrophy trialsAntisense Therapeutics is planning to un...
-
A dedicated electrical impedance myography device in the assessment of Duchenne muscular dystrophyObjective: To evaluate the sensitivity ...
-
Safety Study of Flavocoxid in Duchenne Muscular DystrophyObjective of this study is to evaluate s...
-
A Phase IIa Study of TAS-205 for Duchenne Muscular DystrophyThe objective of this study is to evalua...
-
Phase II Study of NPC-14 (Arbekacin Sulfate) to Explore Safety, Tolerability, and Efficacy in Duchenne Muscular Dyst...Duchenne Muscular Dystrophy (DMD) is inh...
-
Potential DMD Therapy Vamorolone Shows Positive Effects in Phase 2a Trial, Study ReportsVamorolone, a Duchenne muscular dystroph...
-
Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystro...Background: Duchenne muscular dystrophy...
-
Shape Therapeutics’s RNA Editing Gene Therapy Platform Focused on Curing Genetic DiseasesShape Therapeutics, Inc. (ShapeTx), a de...
